A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 4.2B | 4.2B | 3.9B | 3.6B | 3.2B | 3.1B |
| Net Income | 552M | 552M | 732M | 696M | 666M | 766M |
| EPS | $2.45 | $2.45 | $3.25 | $3.23 | $3.13 | $3.59 |
| Free Cash Flow | 1.0B | 1.0B | 401M | 615M | 722M | 839M |
| ROIC | 33.1% | 14.1% | 16.4% | 17.1% | 17.2% | 53.3% |
| Gross Margin | 68.0% | 68.0% | 67.6% | 66.6% | 68.8% | 68.5% |
| Debt/Equity | 0.00 | 1.96 | 1.30 | 0.84 | 2.57 | 0.16 |
| Dividends/Share | $3.34 | $0.76 | $0.72 | $0.73 | $0.71 | $2.86 |
| Operating Income | 1.1B | 1.1B | 1.1B | 985M | 911M | 977M |
| Operating Margin | 25.8% | 25.8% | 27.1% | 27.6% | 28.5% | 31.7% |
| ROE | 26.3% | 26.3% | 32.7% | 27.6% | 56.8% | 59.1% |
| Shares Outstanding | 225M | 225M | 225M | 215M | 213M | 213M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 2.9B | 3.1B | 3.2B | 3.6B | 3.9B | 4.2B | 4.2B |
| Gross Margin | 68.0% | 68.5% | 68.8% | 66.6% | 67.6% | 68.0% | 68.0% |
| R&D | -109M | -120M | -123M | -127M | -132M | -143M | -143M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 902M | 977M | 911M | 985M | 1.1B | 1.1B | 1.1B |
| Op. Margin | 31.6% | 31.7% | 28.5% | 27.6% | 27.1% | 25.8% | 25.8% |
| Net Income | 647M | 766M | 666M | 696M | 732M | 552M | 552M |
| Net Margin | 22.6% | 24.8% | 20.8% | 19.5% | 18.7% | 13.0% | 13.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | 54.0% | 53.3% | 17.2% | 17.1% | 16.4% | 14.1% | 33.1% |
| ROE | 56.7% | 59.1% | 56.8% | 27.6% | 32.7% | 26.3% | 26.3% |
| ROA | 28.1% | 29.8% | 12.5% | 9.8% | 10.5% | 7.5% | 7.5% |
| Cash Flow | |||||||
| Op. Cash Flow | 733M | 839M | 722M | 615M | 401M | 1.0B | 1.0B |
| Free Cash Flow | 733M | 839M | 722M | 615M | 401M | 1.0B | 1.0B |
| Owner Earnings | 602M | 714M | 722M | 615M | 401M | 1.0B | 1.0B |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 131M | 126M | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 131M | 126M | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 557M | 608M | 572M | 618M | 684M | 752M | 752M |
| Dividend Yield | 1.7% | 1.8% | 2.1% | 2.4% | 2.4% | 3.4% | 0.8% |
| Share Buybacks | 77M | 79M | 71M | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.2% | 0.2% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||
| Net Debt | 162M | 134M | 3.0B | 2.0B | 2.8B | 4.0B | -144M |
| Cash & Equiv. | 50M | 71M | 59M | 133M | 114M | 144M | 144M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.19 | 0.16 | 2.57 | 0.84 | 1.30 | 1.96 | 0.00 |
| Interest Coverage | 14.3 | 104.3 | 14.9 | 7.2 | 6.7 | 6.3 | 6.3 |
| Equity | 1.1B | 1.3B | 1.2B | 2.5B | 2.2B | 2.1B | 2.1B |
| Total Assets | 2.3B | 2.6B | 5.3B | 7.1B | 7.0B | 7.4B | 7.4B |
| Total Liabilities | 0 | 0 | 4.2B | 4.6B | 4.8B | 5.3B | 5.3B |
| Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 905M | 1.1B | 913M | 2.3B | 2.4B | 2.3B | 2.3B |
| Working Capital | -176M | -189M | -170M | -1.3B | -347M | 359M | 359M |
| Current Assets | 1.0B | 1.2B | 1.3B | 1.5B | 1.5B | 1.6B | 1.6B |
| Current Liabilities | 1.2B | 1.3B | 1.5B | 2.8B | 1.8B | 1.2B | 1.2B |
| Per Share Data | |||||||
| EPS | 3.03 | 3.59 | 3.13 | 3.23 | 3.25 | 2.45 | 2.45 |
| Owner EPS | 2.83 | 3.35 | 3.39 | 2.86 | 1.78 | 4.47 | 4.47 |
| Book Value | 5.37 | 6.09 | 5.52 | 11.69 | 9.96 | 9.29 | 9.29 |
| Cash Flow/Share | 3.66 | 4.19 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45 |
| Dividends/Share | 2.62 | 2.86 | 0.71 | 0.73 | 0.72 | 0.76 | 3.34 |
| Shares Out. | 212.6M | 212.8M | 212.6M | 215.4M | 224.9M | 225.4M | 225.4M |
| Valuation | |||||||
| P/E Ratio | 51.1 | 46.5 | 38.5 | 35.4 | 34.1 | 34.9 | 173.7 |
| P/FCF | 44.9 | 42.4 | 35.4 | 40.0 | 62.3 | 19.1 | 95.0 |
| EV/EBIT | 36.7 | 36.6 | 31.3 | 27.0 | 26.2 | 21.2 | 87.6 |
| Price/Book | 28.8 | 27.4 | 21.8 | 9.8 | 11.1 | 9.2 | 45.7 |
| Price/Sales | 11.5 | 11.5 | 8.0 | 6.9 | 6.4 | 4.6 | 22.7 |
| FCF Yield | 2.2% | 2.4% | 2.8% | 2.5% | 1.6% | 5.2% | 1.1% |
| Market Cap | 32.9B | 35.6B | 25.6B | 24.6B | 24.9B | 19.2B | 95.8B |
| Avg. Price | 150.66 | 162.48 | 126.35 | 119.90 | 126.66 | 98.63 | 424.90 |
| Year-End Price | 154.72 | 167.09 | 120.33 | 114.30 | 110.90 | 85.37 | 424.90 |
Coloplast B A/S passes 3 of 9 quality checks, indicating weak fundamentals.
Coloplast B A/S trades at 173.7x trailing earnings, compared to its 15-year median P/E of 36.9x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 95.0x vs a median of 41.2x. The company's 5-year average ROIC is 23.6% with a gross margin of 67.9%. Total shareholder yield (dividends) is 0.8%. At current prices, the estimated annualized return to fair value is -3.8%.
Coloplast B A/S (COLO-B-CO) has a current P/E ratio of 173.7, compared to its historical median P/E of 36.9. The stock is currently considered Expensive based on its historical valuation range.
Coloplast B A/S (COLO-B-CO) has a 5-year average return on invested capital (ROIC) of 23.6%. This indicates strong capital allocation and a potential competitive advantage.
Coloplast B A/S (COLO-B-CO) has a market capitalization of $95.8B. It is classified as a large-cap stock.
Yes, Coloplast B A/S (COLO-B-CO) pays a dividend with a trailing twelve-month yield of 0.79%.
Based on historical P/E analysis, Coloplast B A/S (COLO-B-CO) appears expensive. The current P/E of 173.7 is 370% above its historical median of 36.9. The estimated fair value CAGR (P/E method) is -0.1%.
Coloplast B A/S (COLO-B-CO) reported annual revenue of $4.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
Coloplast B A/S (COLO-B-CO) has a net profit margin of 13.0%. This is a healthy margin.
Coloplast B A/S (COLO-B-CO) generated $1.0 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Coloplast B A/S (COLO-B-CO) has a debt-to-equity ratio of 1.96. This indicates higher leverage, which may increase financial risk.
Coloplast B A/S (COLO-B-CO) reported earnings per share (EPS) of $2.45 in its most recent fiscal year.
Coloplast B A/S (COLO-B-CO) has a return on equity (ROE) of 26.3%. This indicates the company generates strong returns for shareholders.
Coloplast B A/S (COLO-B-CO) has a 5-year average gross margin of 67.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 6 years of financial data for Coloplast B A/S (COLO-B-CO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Coloplast B A/S (COLO-B-CO) has a book value per share of $9.29, based on its most recent annual SEC filing.
No recent press releases.